Back to News
Market Impact: 0.45

Itron (ITRI) Stock Declines While Market Improves: Some Information for Investors

ITRISPYDIAQQQ
Company FundamentalsCorporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsMarket Technicals & FlowsTechnology & InnovationInvestor Sentiment & Positioning

Itron (ITRI) shares recently declined 1.31% to $134.84, underperforming the broader market, though the stock had gained 4.45% over the past month, lagging its sector and the S&P 500. Investors are focused on its July 31, 2025 earnings, with Q2 consensus estimates projecting $1.33 EPS (+9.92% YoY) and $609.26 million revenue (+0.03% YoY), while full-year EPS is anticipated to decline. Despite a recent slight reduction in analyst estimates and a Zacks #3 (Hold) rank, ITRI trades at a Forward P/E of 25.08 and a PEG ratio of 0.86, positioning it as potentially undervalued relative to its industry, which is notably ranked in the bottom 7%.

Analysis

Itron (ITRI) demonstrated recent weakness, declining 1.31% to $134.84 while the broader S&P 500 posted a minor gain. Although the stock has appreciated 4.45% over the past month, this lags both the S&P 500's 5.88% rise and its own Computer and Technology sector's 9.6% gain, indicating relative underperformance. Investor focus is now on the upcoming July 31, 2025, earnings release. Projections for the quarter are mixed, with consensus estimates pointing to a healthy 9.92% year-over-year increase in EPS to $1.33, but on virtually flat revenue growth of just 0.03%. The full-year outlook is more cautious, with forecasts for a 3.02% decline in EPS and a marginal 0.76% increase in revenue, compounded by a recent 0.07% downward revision in the Zacks Consensus EPS estimate. From a valuation standpoint, Itron's Forward P/E of 25.08 is aligned with its industry, but its PEG ratio of 0.86 is significantly more attractive than the industry average of 2.67, suggesting potential undervaluation relative to growth. However, this is counterbalanced by a significant headwind: its industry ranks in the bottom 7% of over 250 industries, and the stock holds a neutral Zacks Rank of #3 (Hold).

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo